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Abstract
The following essay was written by a sophomore undergraduate student majoring in Bioengineering
at the University of Maryland, Mr. Zachary Russ. Mr. Russ was one of 174 students who submitted
a 1000–1200 word essay to the 4th Annual Bioethics Contest sponsored by the Institute of
Biological Engineering (IBE). A group of professionals in Biological Engineering assessed and ranked
the essays in a blinded process. Five semi-finalists were invited to present their essays at a session
at the annual meeting of IBE in Santa Clara, CA on March 21, 2009. Five judges scored all the
presentation at the annual meeting and selected Mr. Russ's contribution as the overall winner (1st
Place).
Essay
"It worked" was the understated comment of Manhattan
Project scientific director J. Robert Oppenheimer after wit-
nessing the first nuclear detonation in 1945. Only later
did Oppenheimer reveal that in his mind he had experi-
enced a far grimmer reaction, recalling a passage from the
Bhagavad Gita: "Now I am become Death, the destroyer of
worlds." Oppenheimer's remorse at a moment of scien-
tific triumph was hardly unique. In 1939, after conducting
an early experiment at Columbia University that con-
firmed scientists' ability to split atoms, the physicist Leo
Szilard observed, "We turned the switch, saw the flashes,
then switched everything off and went home. That night I
knew the world was headed for sorrow." In 1969, Erwin
Chargaff, Professor of Biological Chemistry at Columbia,
noted "We manipulate nature as if we were stuffing an
Alsatian goose. We create new forms of energy; we make
new elements; we kill crops; we wash brains. I can hear
them in the dark sharpening their lasers."[1]
The pursuit of knowledge is as old as humankind itself.
Our innate curiosity is reflected in myriad scientific
advances: higher standards of living, longer life spans,
eradication of diseases, exploration of the universe, and
more. Yet we must never forget the horrors that some-
times accompany technological breakthroughs. In 1984, a
pesticide plant in Bhopal, India – established to aid local
agriculture – accidentally released extremely toxic chemi-
cals, killing 3,800 and injuring thousands more [2]. Simi-
larly, the 1986 Chernobyl nuclear reactor disaster killed
dozens and irradiated thousands, forced the evacuation
and resettlement of more than 330,000 people, and
turned 30 kilometers around the plant into a radioactive
no-man's-land [3]. Even a small experiment in 1957 in a
research lab in Brazil to create a more productive honey
bee population went famously awry as the accidental
release of 26 Tanzanian queen "killer" bees led to wide-
spread ecological damage in the Americas and the loss of
dozens of human lives [4].
All these incidents and many others stemmed from a basic
failure to fully evaluate the implications of technological
changes. In modern jargon, they represent "failures in
safety protocols" and are a stark reminder that as we pur-
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sue scientific knowledge, we must be prepared for what-
ever accidents or contingencies may result. Consequently,
I strongly believe the discipline of biological engineering
needs its own code of ethics. Medicine's ancient code of
ethics, the Hippocratic Oath, offers this admonition to
doctors – "First, do no harm." It is a powerful reminder to
all that whatever we do to help humanity can have unex-
pected and undesirable side effects. Therefore, we bioen-
gineers also have a responsibility to our fellow human
beings and to our environment to develop and live by a
code of ethics.
What form should our code take? Biological engineering,
a blossoming field at the crossroads of so many disci-
plines – biology, ecology, chemistry, physics, medicine,
and engineering – exposes itself to unprecedented moral
challenges by making use of so many techniques, includ-
ing genetic engineering, clinical research, and animal
experimentation. No other field encompasses so many
potential pitfalls. It is for this reason that biological engi-
neering needs its own unique code of ethics – it cannot
simply derive its ethics from a parent field, because the
moral questions posed to bioengineers are not a subset of
any other group. Medicine generally does not deal with
the possibility of environmental impact [5](although,
ironically, that assertion now may be changing as pre-
scription medications end up in our waterways[6]); biol-
ogy generally avoids patient research; and chemists and
physicists generally need worry only about laboratory
accidents and environmental contamination. Yet we bio-
logical engineers will have to routinely step over estab-
lished boundaries into uncharted moral territory in
carrying out assignments. It would be useful for us to have
a map by which to align our moral compasses.
So what ethical lines should be drawn on this map? A bio-
engineer is, first and foremost, a human being. As such,
the first element of the code of ethics should include the
basic reminder that in carrying out his or her work, the
bioengineer assumes an enormous responsibility for the
safety and well-being of other people. Designs must incor-
porate safeguards, cautionary procedures, and contin-
gency plans for the possibility of catastrophic failure. A
pioneering example was the first Apollo space mission,
which mandated a three-week quarantine for the return-
ing astronauts on the chance that they might return carry-
ing some unforeseen biological agent from the surface of
the moon [7]. Similarly, a bioengineering oversight could
result in the release of invasive species or infectious
agents, a critical medical device failing to sustain patients,
or an imaging device causing misdiagnoses. These are the
most serious mistakes a bioengineer can make. Therefore,
when it comes to unintended consequences to the public
and the environment, attention to detail is of paramount
importance.
The consideration of safety is found mainly in engineering
codes [8-10]. Related considerations about calling atten-
tion to misconduct and staying within the bounds of
one's competence would also make sense, as a subset of
the previous rule.
However, the bioengineer is likely a researcher as well as
an engineer, as one can see from the numerous research
papers contained in the Journal of Biological Engineering.
Scientific ethical systems focus on honesty – not just hon-
esty about one's qualifications or objective presentation
of facts, but also the explicit prohibition against fabrica-
tion, plagiarism, and exploitation of others [11]. The need
for these rules is obvious, as illustrated by several recent
high-profile research scandals, such as the embryonic
stem-cell cloning scandal [12]. Careers are destroyed and
reputations of entire fields are tarnished every time one of
these cases emerges.
Besides the basics, bioengineers may also find themselves
in more complex moral situations such as live vertebrate
testing, which carries a whole set of ethical concerns that
are currently addressed by publicly available guidelines
[13]. Clinical research in the U.S. is overseen by the
Department of Health and Human Services and the Food
and Drug Administration, where consideration of human
welfare is always critically important [14,15]. However,
because many clinical trials are done overseas and some-
times with minimal regulation, it is essential that our code
of ethics ensure that all patients are well-cared for and not
worse off than if they had not entered the study. Cur-
rently, in the U.S., genetic engineering is mostly unregu-
lated, so special care needs to be taken in designing
guidelines to handle the human species with appropriate
care and respect. Although human genetic enhancements
are a long way away, it is preferable to begin discussing
and examining the subject now, setting down what is and
is not acceptable change in the human genetic composi-
tion, rather than waiting until after the first genetic
enhancement has been made.
Finally, with the explosive growth of bioengineering as a
separate college major and professional discipline, there
will no longer be as many bioengineers who have been
taught ethical considerations derived from other fields. It
will be our responsibility to teach them. Since we must
provide these neophytes a code of ethics, why not teach
one that accurately reflects future needs as varied as the
field itself? For a discipline with as much power to change
the world as nuclear physics before it, bioengineering eth-Publish with BioMed Central    and   every 
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icists certainly will have their work cut out for them. We
must remember that with great power comes great respon-
sibility.
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